Eisai
4523.T
#2026
Rank
ยฃ6.26 B
Marketcap
ยฃ22.21
Share price
-0.60%
Change (1 day)
-44.17%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2023 (TTM): ยฃ1.80

According to Eisai's latest financial reports the company's current EPS (TTM) is ยฃ1.76. In 2022 the company made an earnings per share (EPS) of ยฃ1.29 a decrease over its 2021 EPS that were of ยฃ5.74.

EPS history for Eisai from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)ยฃ1.8039.43%
2022ยฃ1.29-77.48%
2021ยฃ5.74-41.88%
2020ยฃ9.88-0.94%
2019ยฃ9.9752.59%
2018ยฃ6.54124.17%
2017ยฃ2.92-49.42%
2016ยฃ5.7637.08%
2015ยฃ4.21-11.75%
2014ยฃ4.77-3.23%
2013ยฃ4.92-18.56%
2012ยฃ6.05-15.51%
2011ยฃ7.16-3.75%
2010ยฃ7.44-1.36%
2009ยฃ7.54